In a
previously conducted in-depth reimbursement review, the medicine containing
budesonide in tablet form was assessed as generally therapeutically
interchangeable with rectal formulations in the reference indication of
treatment of acute ulcerative colitis affecting the rectum and sigmoid colon.
This conclusion was primarily based on the results of the CORE I and CORE II
studies in a...
Are you interested in reading regular commentaries on decisions by Pharmeca a.s.? Feel free to contact us.
At Pharmeca, we help you navigate the complex landscape of pharmaceutical and medical device information. We also offer flexible services that can be tailored to your needs at any time.
Our market position and experience allow us to support you whenever you need expert guidance.
Our knowledge, your opportunity.
